Cerity Partners
GOSS icon

Cerity Partners’s Gossamer Bio GOSS Stock Holding History

Cerity Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.4K Buy
160,399
+53,880
+51% +$15K ﹤0.01% 3349
2026
Q1 		$35K Buy
106,519
+74,605
+234% +$117K ﹤0.01% 3142
2025
Q4 		$98.9K Buy
31,914
+9,075
+40% +$25.9K ﹤0.01% 2748
2025
Q3 		$60.1K Buy
22,839
+9,078
+66% +$20K ﹤0.01% 2676
2025
Q2 		$16.9K Hold
13,761
– – ﹤0.01% 2609
2025
Q1 		$15.1K Buy
+13,761
New +$15.9K ﹤0.01% 2455

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Cerity Partners's GOSS Position: Q2 2026 in Review

Cerity Partners increased its Gossamer Bio (GOSS) stake by 51% in Q2 2026, buying an estimated $15K and bringing the position to 160,399 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

Cerity Partners first reported a position in GOSS in Q1 2025 and has held it in 6 quarters since. The position peaked at $98.9K in Q4 2025. 150 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Cerity Partners held 160,399 shares of Gossamer Bio worth $26.4K as of Q2 2026.
  • Cerity Partners bought 53,880 Gossamer Bio shares in Q2 2026, an estimated $15K.
  • Gossamer Bio made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3349 holding.
  • Cerity Partners first reported a position in Gossamer Bio in Q1 2025 and has held it in 6 quarters since.
  • Cerity Partners's Gossamer Bio position peaked at $98.9K in Q4 2025.
  • 150 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.